Research Director - LVA Health Outcomes and Medical Engagement Research and Evidence Capabilities (REC) team

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Organization Overview:

At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism

Purpose

The demand for high quality health economic and outcomes research (HEOR), health services research (HSR) and real-world evidence (RWE) to support drug development, health technology assessment/access decisions, product differentiation, clinical decision making, and craft the health policy environment continues to increase. The Lilly Value and Access Health Outcomes and Medical Engagement (LVA HOME) team is looking for dedicated, upbeat, creative, diverse, influential, and collaborative team members to join our function and Team Lilly.

The US healthcare system is dynamic, sophisticated, and constantly evolving. Continuous innovation in the medical and pharmaceutical industry and advances in health information technology and real-world data require our LVA HOME team to continually evolve in order to optimize value for US population-based decision makers (PBDM). The ­­­Director will provide strategic insight/leadership into the evidence needs (e.g., health economics, health services, health policy, patient reported outcomes, real world evidence, access and reimbursement) and RWE capability needs and development for Lilly’s portfolio. The Director will use their knowledge of health outcomes and health services research fields, therapeutic area knowledge of disease states in the Lilly portfolio, understanding of drug development and commercialization, and geographic market knowledge in the role. Research project ownership and execution is required. The Director may have duties ranging from external interaction (e.g. trade organizations, US population-based decision makers, etc) to resolve research and analytics needs, developing and articulating product value propositions, real world evidence generation, and differentiation strategies using HEOR research depending on the individual assignment.

Primary Responsibilities

Strategy

• Drives integration of HEOR from early clinical development through commercialization depending on focus of role.

• Develops HEOR and RWE generation for compounds in the Lilly portfolio relevant to our accelerated research and evidence capability and strategy.

• Serves as a strategic partner on lead/core teams throughout development and/or commercialization, including collaboration with accelerated insights capability leaders to rethink routine and deliver RWE to decision makers in an innovative and personalized manner.

• Formulates and drives real world evidence, and/or economic value strategies for priority products and geographies.

• Develops and leads cross-portfolio (non-business unit specific) health policy research ideation in priority areas.

Study Development and Execution

• Partner with Medical Affairs, develops RWE for products across the lifecycle, to influence and support evidence needs for Lilly products in support of improving patient outcomes.

• Leads research protocol development, including statistical analysis plan, and engage in drafting of manuscripts and external disclosures.

• Leads oversight of research analyst(s) assigned to projects and collaborates closely partners in IT/Tech@Lilly for use of RWD platform.

• Applies technical expertise (e.g., scope or depth in statistical analysis, economic modeling, clinical trials, observational/ epidemiologic research, and health technology or other value assessment).

• Applies disease state knowledge, health policy knowledge, considering of US healthcare industry, and research methods to solve HO and HS issues associated with pricing, reimbursement, and access initiatives.

• Collaborates with decision makers directly and agilely to develop research that supports personalized value propositions.

Organizational Leadership and Influence

• Links technical expert